- Home
- CODX vs BFRI Comparison
CODX vs BFRI Comparison
Compare CODX & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- BFRI
- Stock Information
- Founded
- CODX 2013
- BFRI 1997
- Country
- CODX United States
- BFRI United States
- Employees
- CODX N/A
- BFRI N/A
- Industry
- CODX Medical/Dental Instruments
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- BFRI Health Care
- Exchange
- CODX Nasdaq
- BFRI Nasdaq
- Market Cap
- CODX 9.8M
- BFRI 7.9M
- IPO Year
- CODX 2017
- BFRI 2021
- Fundamental
- Price
- CODX $0.28
- BFRI $0.87
- Analyst Decision
- CODX Buy
- BFRI Strong Buy
- Analyst Count
- CODX 2
- BFRI 1
- Target Price
- CODX $5.50
- BFRI $2.75
- AVG Volume (30 Days)
- CODX 1.1M
- BFRI 216.4K
- Earning Date
- CODX 08-07-2025
- BFRI 08-13-2025
- Dividend Yield
- CODX N/A
- BFRI N/A
- EPS Growth
- CODX N/A
- BFRI N/A
- EPS
- CODX N/A
- BFRI N/A
- Revenue
- CODX $3,497,583.00
- BFRI $37,997,000.00
- Revenue This Year
- CODX N/A
- BFRI $11.75
- Revenue Next Year
- CODX $42.11
- BFRI $17.09
- P/E Ratio
- CODX N/A
- BFRI N/A
- Revenue Growth
- CODX N/A
- BFRI 14.28
- 52 Week Low
- CODX $0.23
- BFRI $0.54
- 52 Week High
- CODX $2.23
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- CODX 51.71
- BFRI 67.76
- Support Level
- CODX $0.26
- BFRI $0.79
- Resistance Level
- CODX $0.29
- BFRI $0.90
- Average True Range (ATR)
- CODX 0.02
- BFRI 0.08
- MACD
- CODX 0.00
- BFRI 0.01
- Stochastic Oscillator
- CODX 64.83
- BFRI 81.19
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.